Surface-enhanced laser desorption ionization-time-of-flight mass spectrometry was employed to identify potential biomarkers for early-onset fibrosis. These biomarkers were then used to evaluate the efficacy of relaxin to reverse or ameliorate the development of the condition.
|Title of host publication||Relaxin and Related Peptides Fifth International Conference|
|Number of pages||3|
|Publication status||Published - Apr 2009|
|Name||Annals of the New York Academy of Sciences|
- Protein profiling
- Relaxin knockout mice
- SELDI-TOF mass spectrometry